Alopexx Enterprises LLC
Alopexx Enterprises LLC is a clinical-stage biotechnology company based in Concord, MA, dedicated to reducing global reliance on antibiotics by developing innovative immune therapeutics. Their approach utilizes a broad-spectrum immune strategy to prevent and treat microbial infections, including those caused by antimicrobial-resistant organisms, through active vaccination and passive immunotherapies.
The company's focus is on poly-N-acetylglucosamine (PNAG), a crucial component found on the surface of a wide range of microbial pathogens, which enables them to adhere to tissues and survive within the body. This extensive distribution of PNAG among various microbes positions Alopexx to offer a meaningful solution in combating one of the greatest medical threats today: antimicrobial resistance (AMR).
Generated from the website
Also at this address
You might also like
Partial Data by Foursquare.
